References
- Fagerström C, Borglin G. Mobility, functional ability and health-related quality of life among people of 60 years or older. Aging Clin Exp Res. 2010;22:387–394.
- Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39:142–148.
- Guyatt GH, Sullivan MJ, Thompson PJ, et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J. 1985;132:919–923.
- Bohannon RW. Six-minute walk test: a meta-analysis of data from apparently healthy elders. Top Geriatr Rehabil. 2007;23:155–160.
- Hill K, Miller K, Denisenko S, et al. Manual for clinical outcome measurement in adult neurological physiotherapy. 2nd ed. St. Kilda: Australian Physiotherapy Association; 2001.
- Mudge S, Stott NS. Outcome measures to assess walking ability following stroke: a systematic review of the literature. Physiotherapy. 2007;93:189–200.
- World Health Organisation. International classification of functioning, disability, and health. Geneva: World Health Organisation; 2001.
- Brogårdh C, Flansbjer U, Espelund C, et al. The 6-minutes walk test indoors is strongly related to walking ability outdoors in persons with late effects of polio. Eur J Physiother. 2013;15:181–184.
- Langhammer B, Stanghelele J, Lindmark B. An evaluation of two different exercise regimes during the first year following stroke: a randomized controlled trial. Physiother Theory Pract. 2009;25:55–68.
- Wirz M, van Hedel HJ, Rupp R, et al. Muscle force and gait performance: relationships after spinal cord injury. Arch Phys Med Rehabil. 2006;87:1218–1222.
- Kottink AI, Hermens HJ, Nene AV, et al. A randomized controlled trial of an implantable 2-channel peroneal nerve stimulator on walking speed and activity in poststroke hemiplegia. Arch Phys Med Rehabil. 2007;88:971–978.
- Goodman AD, Brown TR, Krupp LB, et al. Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. Lancet. 2009;373:732–738.
- Onder G, Penninx BW, Balkrishnan R, et al. Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet. 2002;359:926–930.
- Fritz NE, Worstell AM, Kloos AD, et al. Backward walking measures are sensitive to age-related changes in mobility and balance. Gait Posture. 2013;37:593–597.
- Lam HS, Lau K, Chan GK, et al. The validity and reliability of a 6-metre timed walk for the functional assessment of patients with stroke. Physiother Theory Pract. 2010;26:251–255.
- Eng JJ, Chu KS, Dawson AS, et al. Functional walk tests in individuals with stroke: relation to perceived exertion and myocardial exertion. Stroke. 2002;33:756–761.
- Williams MA, Malm J. Diagnosis and treatment of idiopatic normal pressure hydrocephalus. Continuum. 2016;22:579–599.
- Shprecher D, Schwalb J, Kurlan R. Normal pressure hydrocephalus: diagnosis and treatment. Curr Neurol Neurosci Rep. 2008;8:371–376.
- Fraser JJ, Fraser C. Gait disorder is the cardinal sign of normal pressure hydrocephalus: a case study. J Neurosci Nurs. 2007;39:132–134.
- Fulk GD, Echternach JL, Nof L, et al. Clinometric properties of the six-minute walk test in individuals undergoing rehabilitation poststroke. Physiother Theory Pract. 2008;24:195–204.
- Bo E, Hisdal J, Bergland A. Walking distance and quality of life in patients selected for endovascular treatment. Eur J Physiother. 2013;15:185–192.
- Leahy TE. Impact of a limited trial of walking training using body weight support and a treadmill on the gait characteristics of an individual with chronic, incomplete spinal cord injury. Physiother Theory Pract. 2010;26:483–489.
- Andrews AW, Chinworth SA, Bourassa M, et al. Update on distance and velocity requirements for community ambulation. J Geriatr Phys Ther. 2010;33:128–134.
- Schmid A, Duncan PW, Studenski S, et al. Improvements in speed-based gait classifications are meaningful. Stroke. 2007;38:2096–2100.
- Lederman J, Mendelsohn F, Anderson R, et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. Lancet. 2002;359:2053–2058.